Trials / Unknown
UnknownNCT05290077
Role of NGAL in Vitiligo
Role of Serum NGAL Inearly Detection of CVR in Patients With Vitiligo
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Sohag University · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Role of serum Neutrophil Gelatinase-associated Lipocalin in early detection of cardiovascular risk in patients with Vitiligo
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | NGAL | Serum NGAL in blood for early detection of CVR |
Timeline
- Start date
- 2022-12-15
- Primary completion
- 2022-12-15
- Completion
- 2022-12-15
- First posted
- 2022-03-22
- Last updated
- 2022-10-31
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05290077. Inclusion in this directory is not an endorsement.